Revolutions Medical Launches Its First Company "Spotlight" on Broadcast, Satellite and Cable Television Nationwide Reaching Over 20 Million Households

CHARLESTON, S.C., March 29, 2012 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") RMCP is pleased to announce the launch of its first company "spotlight" through its new media advertising platform. The audience range is expected to reach over 20 million households nationwide on satellite, broadcast and cable television. This program will allow the Company to showcase the design, use and benefits of its RevVac™ auto-retractable vacuum safety syringe in the living room of millions of people. The "video spotlight" or commercial will run for 60-90 seconds, delivering a powerful message about the approximate 800,000 accidental needle sticks in the United States per year, as well as the countless others that occur throughout the world, and the easy solution presented by the RevVac™ auto-retractable vacuum safety syringe. The commercials will air between the hours of 6:00am ET and 12:00am ET throughout the week, starting on Monday April 2, 2012, for three continuous months on DIRECTV, Time Warner Cable and other small broadcast television stations.

Ron Wheet, Chief Executive Officer and Chairman of Revolutions Medical stated, "With the mass production of the RevVac™ auto-retractable vacuum safety syringe underway, this is a very exciting time for the Company as we are transitioning from the development stage to a company dedicated to the production, supply and sales of products servicing the healthcare industry." He continued, "This platform should help create additional brand awareness for the RevVac™ safety syringe, as well as educate the public by revealing the unnecessary risk of accidental needles stick injuries to health care workers that our product could significantly reduce."

Wendy Johnson, President of AMP Media, remarked, "The commercial will enable consumers to view the RevVac™ safety syringe and learn more about the role that this next generation syringe can play in reducing the number of accidental needle sticks and the spread of blood borne diseases. Using the power of video, the Company can both inform and educate consumers, while engaging them in this important healthcare issue."  

To check television airing times and channels visit the media section of the corporate website at www.revolutionsmedical.com.

To view the commercial click on the direct link below:

http://www.revolutionsmedical.com/media/product-videos?file=283.

About Revolutions Medical Corporation

Revolutions Medical is a safety medical device and software application company. Its products include the RevVac™ safety syringe (FDA cleared), safety blood drawing device, the RevColor™, RevDisplay™, and Rev3D™ software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).

For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com

To be added to the Revolutions Medical investor email list, please email: investment@revolutionsmedical.com with RMCP in the subject line.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.